Curcumin and inflammation in non-alcoholic fatty liver disease: a randomized, placebo controlled clinical trial

The aim of the present study was to evaluate the effects of curcumin supplementation on inflammatory indices, and hepatic features in patients with non-alcoholic fatty liver disease (NAFLD).

Source link

Related posts

Are We Close to Targeting Enteric Glia in Gastrointestinal Diseases and Motility Disorders?


MRI biomarker identifies clinical endpoints in PSC


Updated international consensus diagnostic criteria for eosinophilic esophagitis: Proceedings of the AGREE conference


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy